Cardioprotective Benefits of Combined Treatment With Glucagon-Like Peptide-1 Receptor Agonist & Sodium Glucose Transporter-2 Inhibitor In Mice. (June 2018) - Khat, Dorrin Zarrin; Momen, Abdul; Siraj, Muhammad A.; Hadipour-Lakmehsari, Sina; Chandy, Mark J.; Husain, Mansoor